Femme et Homme
- | Pays :
- Japan
- | Organes : -
- | Spécialités : -
Extrait
To investigate the safety, pharmacokinetics, and efficacy following 30-minute continuous intravenous administration of OPC-108459 at 0.4, 0.8, 1.6, or 2.4 mg/kg or placebo to patients with paroxysmal or persistent atrial fibrillation
Critère d'inclusion
- Atrial fibrillation